Frangoul discussed highlights from the latest data update from the CLIMB SCD-121 trial of Casgevy.
Haydar Frangoul, MD, MS
Advertisement
Medical director, pediatric hematology/oncology, Sarah Cannon Pediatric Transplant and Cellular Therapy Program, TriStar Centennial, and investigator, Sarah Cannon Research Institute
Articles by Haydar Frangoul, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
What Are Some Clinical Pearls in Pediatric Dermatology? With Lisa Swanson, MD
2
Plasma EV Analysis Identifies Proteins Associated With T1D Risk, With Ernesto Nakayasu, PhD
3
Looking Beyond TSH in Hypothyroidism Management, With Rosemarie Lajara, MD
4
Tips on Treating Hemangiomas and Molluscum Contagiosum in Children, With Lisa Swanson, MD
5